Publication

[ACS Nano] Scientists designed and evaluated single-component self-assembling protein nanoparticles (SApNPs) presenting the conserved extracellular domain of matrix protein 2 as vaccine candidates against influenza A viruses.

[Scientific Reports] Scientists assessed the association between COVID-19 vaccines, SARS-CoV-2 infection and the risk of thrombocytopenia and venous thromboembolism.

[Nature Communications] Investigators found that the SARS-CoV-2 variants selected for as the virus evolved from the pre-Alpha to the Delta variant had earlier and higher peak in viral load dynamics but a shorter duration of infection.

[Endocrine] Researchers speculated that the adoption of an appropriate technique to inactivate viral particles in saliva specimens allowed the safety maintenance of salivary collections, also during the SARS-CoV-2 outbreak.

[Nature] Investigators used cryo-electron tomography to monitor viral envelope glycoproteinCD4 interactions at the membrane–membrane interfaces formed between HIV-1 and CD4-presenting virus-like particles.

[Nature] Researchers illuminated intermediate conformations of HIV-1envelope and illustrated its structural plasticity.